Effect of Relacorilant on the Pharmacokinetics of the Sensitive P-glycoprotein Substrate Dabigatran Etexilate in Healthy Participants
Phase 1
Completed
- Conditions
- Interventions
- First Posted Date
- 2022-04-27
- Last Posted Date
- 2023-02-09
- Lead Sponsor
- Corcept Therapeutics
- Target Recruit Count
- 30
- Registration Number
- NCT05347979
- Locations
- 🇺🇸
Site 01, Miami, Florida, United States
A Sub Study of the Study Evaluating the Safety, Efficacy, and Pharmacokinetics of Miricorilant in Patients With Presumed Nonalcoholic Steatohepatitis (NASH)
- First Posted Date
- 2022-04-11
- Last Posted Date
- 2024-08-19
- Lead Sponsor
- Corcept Therapeutics
- Target Recruit Count
- 22
- Registration Number
- NCT05320146
- Locations
- 🇺🇸
Site 233, Santa Ana, California, United States
🇺🇸226, Seattle, Washington, United States
🇺🇸305, Houston, Texas, United States
Relacorilant in Combination With Nab-Paclitaxel in Advanced, Platinum-Resistant, High-Grade Epithelial Ovarian, Primary Peritoneal, or Fallopian-Tube Cancer
Phase 3
Active, not recruiting
- Conditions
- Interventions
- First Posted Date
- 2022-02-25
- Last Posted Date
- 2024-08-05
- Lead Sponsor
- Corcept Therapeutics
- Target Recruit Count
- 360
- Registration Number
- NCT05257408
- Locations
- 🇺🇸
Site 272, Atlanta, Georgia, United States
🇺🇸Site 339, Indianapolis, Indiana, United States
🇺🇸Site 127, Pittsburgh, Pennsylvania, United States
A Study Evaluating the Safety, Efficacy, and Pharmacokinetics of Miricorilant in Patients With Presumed Nonalcoholic Steatohepatitis (NASH)
Phase 1
Completed
- Conditions
- Interventions
- First Posted Date
- 2021-11-11
- Last Posted Date
- 2024-08-19
- Lead Sponsor
- Corcept Therapeutics
- Target Recruit Count
- 70
- Registration Number
- NCT05117489
- Locations
- 🇺🇸
Site 207, Chandler, Arizona, United States
🇺🇸Site 214, Panorama City, California, United States
🇺🇸Site 211, Austin, Texas, United States
Single and Multiple Ascending Dose Study of CORT125236 in Healthy Participants
Phase 1
Completed
- Conditions
- Interventions
- First Posted Date
- 2021-08-12
- Last Posted Date
- 2023-03-22
- Lead Sponsor
- Corcept Therapeutics
- Target Recruit Count
- 82
- Registration Number
- NCT05003713
- Locations
- 🇬🇧
Site 01, Ruddington, Nottingham, United Kingdom
Safety, Tolerability, and Pharmacokinetic Study of CORT113176 in Healthy Participants
Phase 1
Completed
- Conditions
- Interventions
- First Posted Date
- 2021-08-06
- Last Posted Date
- 2021-10-11
- Lead Sponsor
- Corcept Therapeutics
- Target Recruit Count
- 16
- Registration Number
- NCT04994743
- Locations
- 🇳🇱
Site 01, Groningen, Netherlands
Single Dose Absorption, Distribution, Metabolism, and Excretion Study of [14C]-CORT113176 in Healthy Male Participants
- First Posted Date
- 2021-08-04
- Last Posted Date
- 2021-11-24
- Lead Sponsor
- Corcept Therapeutics
- Target Recruit Count
- 6
- Registration Number
- NCT04990310
- Locations
- 🇬🇧
Site 01, Ruddington, Nottingham, United Kingdom
T/QT Study to Investigate the Effect of Relacorilant on Cardiac Repolarization in Healthy Volunteers
Phase 1
Completed
- Conditions
- Interventions
- First Posted Date
- 2021-03-12
- Last Posted Date
- 2021-09-14
- Lead Sponsor
- Corcept Therapeutics
- Target Recruit Count
- 36
- Registration Number
- NCT04795479
- Locations
- 🇺🇸
Single Site, Springfield, Missouri, United States
Single and Multiple Dose Study of Miricorilant (CORT118335) Tablet Formulations in Healthy Participants
Phase 1
Completed
- Conditions
- Interventions
- First Posted Date
- 2020-12-17
- Last Posted Date
- 2020-12-17
- Lead Sponsor
- Corcept Therapeutics
- Target Recruit Count
- 36
- Registration Number
- NCT04672499
- Locations
- 🇬🇧
Quotient Sciences, Ruddington, Nottingham, United Kingdom
Single and Multiple Ascending Dose Study of CORT125329 in Healthy Participants
Phase 1
Completed
- Conditions
- Interventions
- First Posted Date
- 2020-12-17
- Last Posted Date
- 2022-02-09
- Lead Sponsor
- Corcept Therapeutics
- Target Recruit Count
- 115
- Registration Number
- NCT04672512
- Locations
- 🇬🇧
Quotient Sciences, Ruddington, Nottingham, United Kingdom
© Copyright 2024. All Rights Reserved by MedPath